Mayor Kate Gallego tapped ASU’s Sethuraman “Panch” Panchanathan to lead a new Phoenix Quantum Strategy aimed at turning the Valley into a quantum hub. The effort will lean on local fabs, bioscience growth and ASU research.

Penn Medicine is using targeted radioactive drugs to shrink tumors in some patients, and new tracers now aim at pancreatic and gastric cancers. Local clinicians say the approach is changing care.

Preliminary inspections show Orion’s heat shield held up during Artemis II’s April 10 splashdown off San Diego, with much less char loss than Artemis I. Engineers say detailed lab work is still coming.

Jumio has named Mark Lorion as CEO as the Sunnyvale firm doubles down on defenses against AI-enabled deepfakes and injection attacks. The hire pairs SaaS go-to-market experience with identity-scale tooling.

Mount Sinai cut the ribbon Sunday on the 216,000‑sq‑ft Irma and Norman Braman Comprehensive Cancer Center in Miami Beach. The center opens to patients May 4 and will expand local cancer care capacity.

Samsung moved chipmaking tools into its Taylor campus, pushing the long‑delayed build toward production and tying the site to a major Tesla chip deal.

New York City startups pulled in $1.6B in late-stage digital health funding in Q1 2026 as investors concentrate on AI-enabled, revenue-generating platforms.

Duquesne installed new signage for the Nasuti College of Osteopathic Medicine after a major gift from Jim and Celeste Nasuti, a change university leaders say will fund scholarships and strengthen clinical training. The sign marks a new phase for the school on Forbes Avenue.

Google DeepMind and South Korea signed an MOU to build an AI campus in Seoul this year, promising internships, joint research and closer ties with Samsung and chipmakers.

Qualcomm jumped after analyst Ming‑Chi Kuo said OpenAI is working with Qualcomm and MediaTek on custom phone chips, with Luxshare named as the manufacturer.

Eli Lilly agreed to buy Ajax Therapeutics for up to $2.3 billion, taking on a Cambridge biotech's experimental Type II JAK2 drug for myelofibrosis with data due in 2026.

China’s NDRC ordered the cancellation of Meta’s acquisition of Manus, forcing parties to withdraw and raising new risks for cross‑border AI deals. The move unsettles Bay Area dealmaking.

A Texas A&M team reports a two‑dose nasal spray made from stem cell‑derived vesicles cut brain inflammation and improved memory in older mice.